I'm a long term holder of ACL. And, totally at loss to understand the current SP. Fonda alone, should be worth about 30-35 cents/share. Which implies market is currently valuing oncology & VAST at abt 30 cents/share.
Why?
Is it lack of NASDQ listing; is it institutional investors not believing the story (several past ACL 'disappointments'); is it lack of faith in management; is it Board/management shortcomings; is it concerns re Phase 3 trial outcomes; is it uncertainties re the real medium-long term value of the HA platform (oncology is a fast moving area); is it 'someone manipulating' the SP; or?
NASDQ listing have boomed over past 12 months; starting just after Audeo backed-out! But, it looks to me like a 'bubble'; and they often burst.
If what we're being told by the company is correct; this stock should be about $3/share. And, today, it's about 20% of that.
Why?
- Forums
- ASX - By Stock
- TSN
- why still grounded - and not flying?
why still grounded - and not flying?
-
- There are more pages in this discussion • 27 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add TSN (ASX) to my watchlist
|
|||||
Last
1.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $1.409M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
TSN (ASX) Chart |
Day chart unavailable
The Watchlist
LU7
LITHIUM UNIVERSE LIMITED
Alex Hanly, CEO
Alex Hanly
CEO
Previous Video
Next Video
SPONSORED BY The Market Online